CONCERT PHARMACEUTICALS, INC. 3 SEC Filings

Filed On	Filing
27 Sep 2019	Form 3: Munsie Jeffrey A, Chief Legal Officer No securities owned
08 May 2019	Form 3: Hoeiland Jesper, Director No securities owned
02 Apr 2019	Form 3: Bvf Partners L P/IL, 10% owner and 6 others Holds 1,377,160 shares of Common Stock, $0.001 par value
08 Jan 2018	Form 3
29 Sep 2017	Form 3: Bvf Partners L P/IL, 10% owner and 6 others Holds 1,457,171 shares of Common Stock, $0.001 par value per share
19 Jun 2017	Form 3: Lynch Ryan, PFO, PAO
06 Jun 2017	Form 3: Herscha Lynette, General Counsel
19 Apr 2016	Form 3: van Heek Christi, Director No securities owned
23 Mar 2016	Form 3: Fitzgerald Meghan, Director No securities owned
04 Feb 2015	Form 3: Cassella James V, Chief Development Officer No securities owned
11 Dec 2014	Form 3: Auchincloss Thomas G, Director No securities owned
17 Mar 2014	Form 3: Wierenga Wendall, Director Holds 12,389 shares of Common Stock
12 Feb 2014	Form 3: Glaxosmithkline Plc, 10% owner
12 Feb 2014	Form 3: New Leaf Ventures I, L.p., 10% owner and 8 others Holds 15,291 shares of Common Stock
12 Feb 2014	Form 3: Adage Capital Partners, L.p., 10% owner and 4 others Holds 14,572 shares of Common stock, par value $0.001 per share
12 Feb 2014	Form 3: Stuart Nancy, Chief Operating Officer
12 Feb 2014	Form 3: Freund John Gordon, Director Holds 32,372 shares of Common Stock
12 Feb 2014	Form 3: Brookside Capital Management Llc, 10% owner and 2 others Holds 32,789 shares of Common Stock
12 Feb 2014	Form 3: Qvt Associates Gp Llc, 10% owner and 1 other
12 Feb 2014	Form 3: Flagship Ventures Fund 2004 L P, 10% owner and 3 others Holds 32,508 shares of Common Stock

Comments